The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Clinical & Manufacturing

Women with gas and bloating: Probiotic clinical trial outcomes
Biotics and Supplements

Women with gas and bloating: Probiotic clinical trial outcomes

SEP 6, 2018
OxThera Phase 3 Study With Oxabact® in Primary Hyperoxaluria is Now Open for Recruitment
Clinical & Manufacturing

OxThera Phase 3 Study With Oxabact® in Primary Hyperoxaluria is Now Open for Recruitment

JUL 15, 2018
Lactobacillus reuteri Reduced Bone Loss in Older Women
Biotics and Supplements

Lactobacillus reuteri Reduced Bone Loss in Older Women

JUN 26, 2018
MHRA and HPRA Clear 4D Pharma’s Blautix Phase II Study
Clinical & Manufacturing

MHRA and HPRA Clear 4D Pharma’s Blautix Phase II Study

JUN 14, 2018
Synlogic Presents New Preclinical Data from Synthetic Biotic™ Medicine, SYNB1020, Highlighting Beneficial Activity in Animal Model of Liver Disease
Clinical & Manufacturing

Synlogic Presents New Preclinical Data from Synthetic Biotic™ Medicine, SYNB1020, Highlighting Beneficial Activity in Animal Model of Liver Disease

JUN 5, 2018
Realm Therapeutics Completes Enrollment in Phase 2 Study of PR022 for Atopic Dermatitis
Clinical & Manufacturing

Realm Therapeutics Completes Enrollment in Phase 2 Study of PR022 for Atopic Dermatitis

MAY 25, 2018
Chr. Hansen reaches major milestone in innovation pipeline
Biotics and Supplements

Chr. Hansen reaches major milestone in innovation pipeline

MAY 16, 2018
Jennewein Biotechnologie: First Clinical Trial of a Blend of Human Milk Oligosaccharides Emulating the Human Profile of Infant Formula
Clinical & Manufacturing

Jennewein Biotechnologie: First Clinical Trial of a Blend of Human Milk Oligosaccharides Emulating the Human Profile of Infant Formula

MAY 6, 2018
AOBiome Therapeutics Expands Clinical-Stage Pipeline, Initiates Phase 2 Clinical Trial for Episodic Migraine
Clinical & Manufacturing

AOBiome Therapeutics Expands Clinical-Stage Pipeline, Initiates Phase 2 Clinical Trial for Episodic Migraine

APR 23, 2018
Second Genome Presents Clinical and Preclinical Data Supporting Development of Its P2X7 Inhibitor, SGM-1019, in NASH at the EASL International Liver Congress 2018
Clinical & Manufacturing

Second Genome Presents Clinical and Preclinical Data Supporting Development of Its P2X7 Inhibitor, SGM-1019, in NASH at the EASL International Liver Congress 2018

APR 9, 2018
AOBiome Therapeutics Reports Positive Clinical Safety Results for First-in-Class Microbiome-Targeted Therapy for Intranasal Delivery
Clinical & Manufacturing

AOBiome Therapeutics Reports Positive Clinical Safety Results for First-in-Class Microbiome-Targeted Therapy for Intranasal Delivery

MAR 21, 2018